Ofloxacin: Clinical Trials

4 trials of Ofloxacin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 1, Terminated 1

Follow Ofloxacin: new trials by email Literature Review of Ofloxacin trials Research Report on Ofloxacin

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis
Levofloxacin 0.5% - Cutaneous Leishmaniasis
Phase 2RecruitingHayder Adnan Fawzi402025-02-092025-09-30
Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB
Levofloxacin, Optimized background regimen (OBR) - Tuberculosis, Multidrug-Resistant
Phase 2CompletedBoston University1112015-01-012023-05-24
The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers
gentamicin-collagen sponge and levofloxacin, Levofloxacin only - Diabetic Foot Ulcer
Phase 2CompletedInnocoll562008-04-012022-01-27
The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases
Treatment of predefined abnormality by hysteroscopic surgery, Ofloxacinum/Doxycycline - Minor Intra-uterine Abnormalities
Phase 2TerminatedUMC Utrecht7002007-06-012015-06-04

Conditions studied

Diabetes Mellitus (1)  ·  Diabetic Foot (1)  ·  Endometritis (1)  ·  Infections (1)  ·  Leishmaniasis, Cutaneous (1)  ·  Myoma (1)  ·  Polyps (1)  ·  Tissue Adhesions (1)  ·  Tuberculosis, Multidrug-Resistant (1)  ·  Ulcer (1)

Sponsors

Boston University (1)  ·  Hayder Adnan Fawzi (1)  ·  Innocoll (1)  ·  UMC Utrecht (1)

Countries

Iraq (1)  ·  Netherlands (1)  ·  Peru (1)  ·  South Africa (1)  ·  United States (1)

Top investigators

Charles R Horsburgh, MD (1)  ·  David Prior (1)  ·  Frank JM Broekmans, Dr. (1)  ·  Human M Fatemi, Dr. (1)  ·  Jenneke C Kasius (1)  ·  Paul Devroey, Prof. dr. (1)

Results publications

PMID 22659765, PMID 23499151, PMID 29178937, PMID 30012767, PMID 30373800, PMID 35996282, PMID 40080768

NIH funding

U01AI100805 (1)